Among the various LRPs, LRP1 and Very Low-Density Lipoprotein Receptor (VLDLR) are suggested for modulating Aβ levels and influencing the progression of AD (Deane et al., 2004, 2008). Here, LRP1 is linked to Alzheimer disease.